Skip to Main Content

Paper Details

Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada.
Kidney Med
2
2023
Author NameAffiliation
Amit X Garg
Amit X GargWestern University
Brenda R HemmelgarnUniversity of Alberta
Matthew T JamesCumming School of Medicine, University of Calgary
Matthew T JamesLibin Cardiovascular Institute of Alberta, University of Calgary
Eric McArthur
Zhi TanCumming School of Medicine, University of Calgary
Martin GallagherThe George Institute for Global Health
Martin GallagherLiverpool Clinical School
  • 1 - 9

Datasets

Release 1.2